FDA Holding Workshop to Explore Artificial Intelligence in Radiology

Public comments are open for discussion about safety and effectiveness of AI in medical imaging

Registration is now open for the U.S. Food and Drug Administration’s (FDA) two-day public workshop to explore the use of artificial intelligence (AI) in radiology.

The workshop entitled, “Evolving Role of Artificial Intelligence in Radiological Imaging,” will be held Feb. 25-26, 2020, in Bethesda, MD, and will feature sessions and discussion panels about the emerging applications of AI in radiological imaging. Topics on the agenda for the workshop include radiological AI device regulation, emerging trends in software and machine-guided image acquisition. The workshop’s goal is to develop a better understanding of the risks and rewards of AI’s burgeoning use in imaging and identify any possible dangers as machine-learning technologies evolve.

The FDA is currently accepting public comments through March 26, 2020 about AI and the topics identified for this workshop.

Admission to the workshop is free, but attendees must register to reserve a seat. The workshop will be available via webcast following the event.